BerGenBio ASA (OSL:BGBIO)
Norway
· Delayed Price · Currency is NOK 1.818
+0.118 (6.92%)
Apr 1, 2025, 3:20 PM CET
BerGenBio ASA Market Cap
BerGenBio ASA has a market cap or net worth of 71.04 million as of April 1, 2025. Its market cap has decreased by -85.32% in one year.
Market Cap
71.04M
Enterprise Value
-68.29M
Revenue
848.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
1.82
Market Cap Chart
Since April 7, 2017, BerGenBio ASA's market cap has decreased from 1.24B to 71.04M, a decrease of -94.29%. That is a compound annual growth rate of -30.12%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 3.16B |
| Nordhealth AS | 3.00B |
| Photocure ASA | 1.55B |
| Vistin Pharma ASA | 1.09B |
| Hofseth BioCare ASA | 1.02B |
| Omda AS | 844.92M |
| ArcticZymes Technologies ASA | 833.49M |
| Thor Medical ASA | 786.02M |